tiprankstipranks
Trending News
More News >

SpringWorks Therapeutics downgraded to Neutral from Outperform at Wedbush

Wedbush downgraded SpringWorks Therapeutics (SWTX) to Neutral from Outperform after Merck KGaA (MKGAY) and SpringWorks announced the companies have entered into a definitive agreement for Merck KGaA to acquire SpringWorks for $47 per share in cash.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1